Waters Completes Merger with BD's Biosciences and Diagnostic Solutions Businesses
Waters has completed its merger with BD’s Biosciences and Diagnostic Solutions businesses, creating a global life sciences and diagnostics leader focused on high-volume testing in regulated applications, alongside announcing the appointment of Claire M Fraser, PhD, to its Board and the formation of four new operating divisions.
Becton, Dickinson And Company | 10/02/2026 | By News Bureau
BD has launched Research Cloud 7.0 globally, introducing the AI-driven Horizon Panel Maker to automate panel design, streamline workflows and enhance data quality in immunology and cancer research.
Becton, Dickinson And Company | 27/01/2026 | By News Bureau | 135
BD Secures FDA 510(k) Clearance for EnCor EnCompass Multi-Modality Breast Biopsy System
BD has received FDA 510(k) clearance for its EnCor EnCompass multi-modality breast biopsy system, designed to improve procedural efficiency, clinician flexibility and early detection and diagnosis of breast disease.
Becton, Dickinson And Company | 17/01/2026 | By News Bureau | 101
BD and Opentrons Collaborate to Automate Single-Cell Multiomics Workflows
BD (Becton, Dickinson and Company) and Opentrons Labworks, Inc. have entered into a multi-year collaboration to accelerate advances in single-cell multiomics research by integrating robotic automation into critical laboratory workflows.
Becton, Dickinson And Company | 08/10/2025 | By Darshana | 343
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy